title: Continuous measurements of plasma protein extravasation with microdialysis after various inflammatory challenges in rat and mouse skin.
abstract: This study describes the use of microdialysis technique for continuous measurement of plasma protein extravasation (PPE) in rat and mouse skin with drug application either intravenously or via the microdialysis fiber. Hollow plasmapheresis fibers (3-cm length, 0.4-mm diameter, cutoff 3,000 kDa) were placed subcutaneously on the back of anesthetized mice and rats. Intravenous injection of dextran (Macrodex, 60 mg/ml) increased PPE by 355% from baseline within 30 min in rats with ligated kidneys (n = 6; P < 0.05) but not in animals with intact kidneys. Phalloidin (500 microg/kg iv 40 min before dextran, n = 6; P < 0.05) did not change the response to dextran in either group. Animals receiving PGE1, compound 48/80 (mice), paclitaxel, docetaxel, and cremophor EL via the microdialysis fiber were also provided with a control fiber receiving vehicle. Both rats and mice had constant PPE in the control fiber, and there was no change in PPE in the NaCl-treated groups (rats, n = 4; mice, n = 6). Application via the fiber of PGE1 (20 microg/ml), compound 48/80 (mice; 4 mg/ml), and docetaxel (0.5 mg/ml) increased PPE compared with baseline within 60 min by 139% (n = 6; P < 0.05), 273% (n = 6; P < 0.05), and 325% (n = 5; P < 0.05), respectively. Phalloidin alone did not increase PPE (n = 5; P < 0.05). Pretreatment with phalloidin did not inhibit the increase after PGE1 or compound 48/80 but inhibited that after docetaxel (n = 6). Paclitaxel (0.6 mg/ml, n = 5) or vehicle (Cremophor) (n = 5) gave no increase in PPE. The results demonstrate that microdialysis can be used to continuously measure changes in PPE after inflammatory challenges in skin of rats and mice.
authors.affiliation: Department of Physiology, Jonas Lies vei 91, N-5009 Bergen, Norway. vegard.iversen@fys.uib.no
authors.forename: V V
authors.initials: VV
authors.lastname: Iversen
authors.forename: A
authors.initials: A
authors.lastname: Bronstad
authors.forename: E-A B
authors.initials: EA
authors.lastname: Gjerde
authors.forename: R K
authors.initials: RK
authors.lastname: Reed
mesh_terms: D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism*; D003872:Dermatitis / Q000378:metabolism*; D003911:Dextrans / Q000494:pharmacology; D000077143:Docetaxel; D005260:Female; D051379:Mice; D008810:Mice, Inbred C57BL; D017551:Microdialysis; D010539:Permeability / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D012867:Skin / Q000378:metabolism*; D043823:Taxoids / Q000494:pharmacology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
chemical_list: D001798:Blood Proteins; D003911:Dextrans; D043823:Taxoids; D000077143:Docetaxel; D003189:p-Methoxy-N-methylphenethylamine; D000527:Alprostadil